Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38,512,859
-
Total 13F shares
-
24,125,809
-
Share change
-
+78,662
-
Total reported value
-
$27,021,270
-
Price per share
-
$1.12
-
Number of holders
-
38
-
Value change
-
+$88,269
-
Number of buys
-
15
-
Number of sells
-
12
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q4 2023
As of 31 Dec 2023,
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,125,809 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, Vivo Capital, LLC, Sofinnova Investments, Inc., CITADEL ADVISORS LLC, Pivotal bioVenture Partners Investment Advisor LLC, Newtyn Management, LLC, ORBIMED ADVISORS LLC, Nan Fung Group Holdings Ltd, Samsara BioCapital, LLC, and VANGUARD GROUP INC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.